TipRanks
BlossomHill Therapeutics, Inc. (BLSM)
NASDAQ:BLSM
US Market
BLSM
BlossomHill Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see BLSM full AI Analyst Report?

BlossomHill Therapeutics, Inc. (BLSM) Income Statement

17 Followers

BlossomHill Therapeutics, Inc. Income Statement

Last quarter (Q2 2026), BlossomHill Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from previous quarter. In Q2, BlossomHill Therapeutics, Inc.'s net income was $-23.76M. See BlossomHill Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00
Operating Expenses
$ 64.02M$ 36.40M
Depreciation and Amortization
$ 441.00K$ 350.00K
EBITDA
$ -63.58M$ -36.05M
Operating Income
$ -64.02M$ -36.40M
Other Income/Expenses
$ 3.47M$ 5.71M
Pretax Income
$ -60.55M$ -30.70M
Net Income
$ -60.55M$ -30.70M
Per Share Metrics
Basic EPS
$ -2.08$ -1.06
Diluted EPS
$ -2.08$ -1.06
Weighted Average Shares Outstanding
 29.08M 29.08M
Weighted Average Shares Outstanding (Diluted)
 29.08M 29.08M
Currency in USD

BlossomHill Therapeutics, Inc. Earnings and Revenue History